TD Cowen Initiates Coverage on Palvella Therapeutics (NASDAQ:PVLA)

Stock analysts at TD Cowen began coverage on shares of Palvella Therapeutics (NASDAQ:PVLA) in a research note issued on Wednesday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $44.00 price target on the stock. TD Cowen’s price objective suggests a potential upside of 216.77% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Cantor Fitzgerald initiated coverage on Palvella Therapeutics in a report on Wednesday, December 18th. They issued an “overweight” rating for the company. HC Wainwright reiterated a “buy” rating and issued a $38.00 price objective on shares of Palvella Therapeutics in a report on Friday, January 10th.

Palvella Therapeutics Trading Up 7.1 %

Shares of PVLA opened at $13.89 on Wednesday. Palvella Therapeutics has a 12-month low of $6.20 and a 12-month high of $22.32. The firm has a market cap of $155.85 million, a PE ratio of -1.15 and a beta of 0.68.

Insider Activity at Palvella Therapeutics

In other Palvella Therapeutics news, Director George M. Jenkins purchased 4,000 shares of the stock in a transaction on Wednesday, December 18th. The stock was bought at an average cost of $12.93 per share, for a total transaction of $51,720.00. Following the completion of the acquisition, the director now directly owns 180,671 shares of the company’s stock, valued at $2,336,076.03. The trade was a 2.26 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 6.39% of the stock is currently owned by corporate insiders.

About Palvella Therapeutics

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc, formerly known as Pieris Pharmaceuticals Inc, is based in WAYNE, Pa.